BIO Japan 2026

Richmond Pharmacology is excited to join BioJapan 2026 in Yokohama, Japan, on  07- 09 October 2026.

Connecting global leaders in biotechnology and life sciences, BioJapan is a premier platform for fostering partnerships, sharing cutting-edge research, and driving innovation across the healthcare and pharmaceutical sectors.

Representing Richmond Pharmacology

• Dr Jörg Taubel, Chief Executive Officer

• Stephen Wilkinson, Business Development Manager

• Nobuo Ittetsu, Head of Japanese Volunteer Recruitment

• Minoru Takada, Japanese Business Development Executive

We look forward to connecting with attendees to discuss Richmond’s expertise in:

• Innovations in biotechnology and clinical trial design

• Regulatory pathways for emerging therapies

• Patient-centric approaches and recruitment strategies

• Collaboration between academia, industry, and regulators

• Data-driven solutions for accelerating development

Connect With Us

If you are attending BioJapan 2026 and would like to explore partnership or development opportunities email us at: 📧 fasteranswers@richmondpharmacology.com

‍